IL17A and psoriasis: While this polymorphism conferred protection to psoriasis, a Th17-driven disease successfully treated with anti-IL-17 monoclonal antibodies (36), it has been associated with increased severity in ulcerative colitis (37), primary lung graft dysfunction and neutrophilia, indicating a potential role in inflammatory responses (38).